µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
Ç÷¾× ¹× Á¶Ç÷±â°ü °ü·Ã ¾à¹° (Blood & Hematopoietic Related Agents)
  Ç÷Àü¿ëÇØÁ¦ (Fibrinolytics, Thrombolytic Agents)
  Urokinase 50IU
 
°Ë»öµÈ Á¦Ç°¸í (À¯ÅëÁßÀÎ Á¦Ç°) ÃÑ 0°³
´ëÁ¶¾à:¡Ü »ýµ¿¼º½ÃÇè¿Ï·á:¡Ü ºñ±³¿ëÃâ½ÃÇè¿Ï·á:¡Ü
Á¦Ç°¸í ÆÇ¸Å»ç ±¸ºÐ º¸Çè º¸Çè°¡ ´ëü
°Ë»ö°á°ú°¡ ¾ø½À´Ï´Ù.
»èÁ¦.¹Ì»ý»ê Á¦Ç° (À¯ÅëµÇÁö ¾ÊÀº Á¦Ç°) ÃÑ 10°³
Á¦Ç°¸í ÆÇ¸Å»ç ±¸ºÐ »ý»ê¿©ºÎ
³ì½ÊÀÚÀ¯·ÎÅ°³ªÁ¦ÁÖ500000´ÜÀ§(ÁÖ)³ì½ÊÀÚÀü¹® 
³ì½ÊÀÚÀ¯·ÎÅ°³ªÁ¦ÁÖ50¸¸´ÜÀ§(ÁÖ)³ì½ÊÀÚÀü¹® 
¼¼Á¾À¯·Î³ªÁ¦ÁÖ50¸¸iu¼¼Á¾Á¦¾àÀü¹® 
½ÅdzÀ¯·ÎÅ°³ªÁ¦ÁÖ500000´ÜÀ§½ÅdzÁ¦¾à(ÁÖ)Àü¹® 
½ÅdzÀ¯·ÎÅ°³ªÁ¦ÁÖ50¸¸´ÜÀ§½ÅdzÁ¦¾à(ÁÖ)Àü¹® 
¾¾Á¦ÀÌÀ¯·ÎÅ°³ªÁ¦500,000¾ÆÀÌÀ¯¿¡ÀÌÄ¡ÄÉÀÌÀ̳뿣(ÁÖ)Àü¹® 
À¯·ÎƾÁÖ500000I.U.(À¯·ÎÅ°³ªÁ¦)Çѱ¹À¯³ªÀÌƼµåÁ¦¾à(ÁÖ)Àü¹® 
À¯·ÎƾÁÖ50¸¸´ÜÀ§Çѱ¹À¯³ªÀÌƼµåÁ¦¾à(ÁÖ)Àü¹® 
À¯ÇÑÀ¯·ÎÅ°³ªÁ¦ÁÖ500000´ÜÀ§(ÁÖ)À¯ÇѾçÇàÀü¹® 
ÄÉÀ̵ðÀ¯³ªÁ¦ÁÖ50¸¸´ÜÀ§°æµ¿Á¦¾à(ÁÖ)Àü¹® 
[1]
 
ºñÆ®µå·¯±×ÀÎÆ÷